Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b

C Polman; L Kappos; MS Freedman; G Edan; HP Hartung; DH Miller; K Koivisto; X Montalbán; F Barkhof; K Selmaj; BMJ Uitdehaag; S Dahms; L Bauer; C Pohl; R Sandbrink; Irina Elovaara

doi:10.1007/s00415-007-0733-2

Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b

C Polman, L Kappos, MS Freedman, G Edan, HP Hartung, DH Miller, K Koivisto, X Montalbán, F Barkhof, K Selmaj, BMJ Uitdehaag, S Dahms, L Bauer, C Pohl, R Sandbrink, Irina Elovaara

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

70 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	480-487
Julkaisu	J Neurol
Vuosikerta	255
Numero	4
DOI - pysyväislinkit	https://doi.org/10.1007/s00415-007-0733-2
Tila	Julkaistu - 2008
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Tutkimusalat

CIS
MRI
multiple sclerosis

Pääsy asiakirjaan

10.1007/s00415-007-0733-2

Siteeraa tätä

Polman, C., Kappos, L., Freedman, MS., Edan, G., Hartung, HP., Miller, DH., Koivisto, K., Montalbán, X., Barkhof, F., Selmaj, K., Uitdehaag, BMJ., Dahms, S., Bauer, L., Pohl, C., Sandbrink, R., & Elovaara, I. (2008). Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b. J Neurol, 255(4), 480-487. https://doi.org/10.1007/s00415-007-0733-2

@article{04e2a6c3cc914b55aa13359689516ee0,

title = "Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b",

keywords = "CIS, MRI, multiple sclerosis, CIS, MRI, multiple sclerosis",

author = "C Polman and L Kappos and MS Freedman and G Edan and HP Hartung and DH Miller and K Koivisto and X Montalb{\'a}n and F Barkhof and K Selmaj and BMJ Uitdehaag and S Dahms and L Bauer and C Pohl and R Sandbrink and Irina Elovaara",

year = "2008",

doi = "10.1007/s00415-007-0733-2",

language = "English",

volume = "255",

pages = "480--487",

number = "4",

}

Polman, C, Kappos, L, Freedman, MS, Edan, G, Hartung, HP, Miller, DH, Koivisto, K, Montalbán, X, Barkhof, F, Selmaj, K, Uitdehaag, BMJ, Dahms, S, Bauer, L, Pohl, C, Sandbrink, R & Elovaara, I 2008, 'Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b', J Neurol, Vuosikerta 255, Nro 4, Sivut 480-487. https://doi.org/10.1007/s00415-007-0733-2

TY - JOUR

T1 - Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b

AU - Polman, C

AU - Kappos, L

AU - Freedman, MS

AU - Edan, G

AU - Hartung, HP

AU - Miller, DH

AU - Koivisto, K

AU - Montalbán, X

AU - Barkhof, F

AU - Selmaj, K

AU - Uitdehaag, BMJ

AU - Dahms, S

AU - Bauer, L

AU - Pohl, C

AU - Sandbrink, R

AU - Elovaara, Irina

PY - 2008

Y1 - 2008

KW - CIS

KW - MRI

KW - multiple sclerosis

KW - CIS

KW - MRI

KW - multiple sclerosis

U2 - 10.1007/s00415-007-0733-2

DO - 10.1007/s00415-007-0733-2

M3 - Article

SN - 0340-5354

VL - 255

SP - 480

EP - 487

JO - J Neurol

JF - J Neurol

IS - 4

ER -